Adaptive Pathways: Companies Advised To Consider Hurdles As EMA Accepts More Applications

The European Medicines Agency has released its keenly awaited final report on it adaptive pathways pilot and says it will continue to accept applications for the new drug development concept. Meanwhile, law firm Bristows highlights the hurdles ahead for applicants.